Jiro Fujiyama

Myopathy Induced by HMG–CoA Reductase Inhibitors in Rabbits: A Pathological, Electrophysiological, and Biochemical Study

Keiichi Nakahara, Masaru Kuriyama, Yoshito Sonoda et al. · Toxicology and Applied Pharmacology · 1998 · 119 citations

Myopathy Induced, Disease Pathophysiology, Medicine +7

Atherogenic risk factors in cerebrotendinous xanthomatosis

Jiro Fujiyama, Masaru Kuriyama, Sinichi Arima et al. · Clinica Chimica Acta · 1991 · 61 citations

Histopathology, Atherogenic Risk Factors, Pathology +3

Mechanism of methylmercury efflux from cultured astrocytes

Jiro Fujiyama, Kimiko Hirayama, Akira Yasutake · Biochemical Pharmacology · 1994 · 40 citations

Molecular Physiology, Ependyma, Epigenetic Change +6

Treatment of cerebrotendinous xanthomatosis with low-density lipoprotein (LDL)-apheresis

Yoshihiro Mimura, Masaru Kuriyama, Yoshika Tokimura et al. · Journal of the Neurological Sciences · 1993 · 29 citations

Thrombosis, Lipid Disorder, Low-density Lipoprotein +8

Parkinsonism in cerebrotendinous xanthomatosis.

Jiro Fujiyama, Masaru Kuriyama, Hiroaki Yoshidome et al. · Japanese Journal of Medicine · 1991 · 19 citations · Full text

Hand Tremor, Neurodegenerative Diseases, Corticobasal Degeneration +14